Synthetic Biologics (SYN) Misses Q3 EPS by 10c

Synthetic Biologics (NYSE: SYN) reported Q3 EPS of ($0.14), $0.10 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Synthetic Biologics (SYN) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Wolfspeed (WOLF) Misses Q4 EPS by 174c; Offers Guidance
• Marti Technologies (MRT) Misses Q2 EPS by 9c ; Offers Guidance